EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Differences in tumor and normal tissue concentrations of iodine and indium labeled monoclonal antibody i. the effect on image contrast in clinical studies






European Journal of Nuclear Medicine 11(8): 295-299

Differences in tumor and normal tissue concentrations of iodine and indium labeled monoclonal antibody i. the effect on image contrast in clinical studies

The poor imaging characteristics of 131I have resulted in the use of alternative radionuclides for radiolabelling monoclonal antibodies. Clinical imaging studies have shown that, in addition to the more suitable energy of emission of 111In over 131I for gamma camera detection, the 111In-labelled antibody appears to celar from the blood-stream at a faster rate than that of 131-labelled antibody, resulting in greater tumour-to-background image contrast. However, measurements of the activity in blood samples from patients demonstrate that both 131I- and 111In-labelled antibodies clear from the circulation at similar rate. This discrepancy is probably due to the different biological fates of the two radionuclides and warrants further scientific study.

(PDF 0-2 workdays service: $29.90)

Accession: 005151703

PMID: 4076237



Related references

Differences in tumor and normal tissue concentrations of iodine and indium labeled monoclonal antibody ii. biodistribution studies in mice with human tumor xenografts. European Journal of Nuclear Medicine 11(8): 300-304, 1985

Metabolism of indium-111-labeled murine monoclonal antibody in tumor and normal tissue of the athymic mouse. Journal of Nuclear Medicine 31(9): 1510-1519, 1990

The effect of tumor CEA content and tumor size on tissue uptake of indium 111-labeled anti-CEA monoclonal antibody. Cancer 57(3): 571-576, 1986

Mean time parameters reveal differences in the pharmacokinetics of indium-111 and iodine-131-labeled B72.3 monoclonal antibody. Journal of Nuclear Medicine 33(12): 2248-2250, 1992

In vitro differences in metabolism of indium 111 yttrium 90 and iodine 125 labeled t101 monoclonal antibody. Journal of Nuclear Medicine 28(4 SUPPL): 693, 1987

Reproducibility of image interpretation in labeled immunoscintigraphy performed with indium 111 labeled and iodine 131 labeled oc 125 fab2 antibody injected into the same patients. European Journal of Nuclear Medicine 16(7): 452, 1990

The effect of tumor carcinoembryonic antigen content and tumor size on tissue uptake of indium 111 labeled anti carcinoembryonic antigen monoclonal antibody. Cancer 57(3): 571-576, 1986

Thrombus detection in the canine model using iodine 131 labeled and indium 111 labeled antiplatelet monoclonal antibody. American Heart Association Monograph (114): III-467, 1985

Reproducibility of image interpretation in immunoscintigraphy performed with indium 111 labeled and iodine 131 labeled oc125 fab' 2 antibody injected into the same patients. Journal of Nuclear Medicine 32(2): 221-227, 1991

Effect of two dose levels of unlabeled antibody on lung tumor uptake of indium 111 labeled anti cea monoclonal antibody moab. Journal of Nuclear Medicine 29(5 SUPPL): 825, 1988